Trigyn Technologies Reports Q3FY26 Results with Revenue Growth but Lower Profits

2 min read     Updated on 10 Feb 2026, 08:41 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Trigyn Technologies Limited reported Q3FY26 results showing consolidated revenue growth to Rs. 25,803.19 Lakhs from Rs. 24,195.14 Lakhs in the previous quarter, but profit after tax declined to Rs. 69.12 Lakhs from Rs. 527.21 Lakhs. For nine months FY26, consolidated revenue increased to Rs. 72,448.30 Lakhs from Rs. 65,731.72 Lakhs year-over-year, while profit dropped significantly to Rs. 135.45 Lakhs from Rs. 921.16 Lakhs in the corresponding period last year.

32281917

*this image is generated using AI for illustrative purposes only.

Trigyn Technologies Limited has announced its financial results for the third quarter ended December 31, 2025, showing mixed performance with revenue growth but declining profitability across both quarterly and nine-month periods.

Consolidated Financial Performance

Quarterly Results (Q3FY26)

The company reported sequential revenue growth in the third quarter, with consolidated revenue increasing to Rs. 25,803.19 Lakhs compared to Rs. 24,195.14 Lakhs in the previous quarter ended September 30, 2025. However, profitability declined significantly during the same period.

Metric Q3FY26 Q2FY26 Change
Revenue Rs. 25,803.19 Lakhs Rs. 24,195.14 Lakhs Growth
Profit After Tax Rs. 69.12 Lakhs Rs. 527.21 Lakhs Decline

Nine-Month Performance (9M FY26)

For the nine months ended December 31, 2025, Trigyn Technologies demonstrated year-over-year revenue growth on a consolidated basis. The company earned revenue of Rs. 72,448.30 Lakhs compared to Rs. 65,731.72 Lakhs in the corresponding nine-month period of the previous year.

Parameter 9M FY26 9M FY25 Performance
Consolidated Revenue Rs. 72,448.30 Lakhs Rs. 65,731.72 Lakhs +10.22% Growth
Profit After Tax Rs. 135.45 Lakhs Rs. 921.16 Lakhs -85.29% Decline

Standalone Financial Results

Nine-Month Standalone Performance

On a standalone basis, the company showed strong revenue growth for the nine-month period. Revenue increased to Rs. 14,162.45 Lakhs in 9M FY26 from Rs. 10,605.00 Lakhs in 9M FY25, representing significant year-over-year improvement. However, the company reported a loss of Rs. (518.09) Lakhs compared to a profit of Rs. 68.27 Lakhs in the previous year.

Quarterly Standalone Results

For the quarter ended December 31, 2025, standalone revenue reached Rs. 6,279.23 Lakhs, substantially higher than Rs. 4,342.20 Lakhs in the previous quarter. The company returned to profitability with earnings of Rs. 132.93 Lakhs compared to a loss of Rs. (152.00) Lakhs in Q2FY26.

Metric Q3FY26 Standalone Q2FY26 Standalone Change
Revenue Rs. 6,279.23 Lakhs Rs. 4,342.20 Lakhs +44.58% Growth
Profit/(Loss) Rs. 132.93 Lakhs Rs. (152.00) Lakhs Return to Profit

About Trigyn Technologies

Trigyn Technologies, established in 1986, operates as a public multinational Information Technology firm with 2,000 resources deployed across 25 countries in Asia, North America, Europe, and Africa. The company serves major Fortune 500 companies across diverse industries, intergovernmental organizations, and US state governments. The company's service portfolio includes unified command and control centers, smart solutions, Internet of Things (IoT), smart utilities, and security surveillance systems. Trigyn Technologies maintains industry certifications including ISO 9001:2015, ISO 27001:2013, and CMMI V2.0 Dev ML5, with strategic partnerships with technology leaders like Microsoft, IBM, AWS, SAP, and Oracle.

Historical Stock Returns for Trigyn Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.61%+17.55%+3.72%-19.21%-32.72%-19.43%

Trigyn Technologies Secures Approval for 4.5 Lakh Equity Shares Under ESOP 2025

2 min read     Updated on 12 Aug 2025, 08:50 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Trigyn Technologies Limited (TTL) received approval from NSE and BSE to list 4,50,000 equity shares under its Employee Stock Option Plan 2025. The approval is subject to compliance with SEBI regulations and other conditions. However, TTL's Q1 FY2025-26 financial results show a decline, with consolidated revenue dropping to ₹22,450.00 lakhs and a net loss of ₹460.86 lakhs. The company also faces challenges including arbitration proceedings with NMSCDCL and a GST department notice for ₹9.08 crores. On the positive side, TTL approved new roles for an executive and received approval to incorporate a subsidiary in Dubai.

16557622

*this image is generated using AI for illustrative purposes only.

Trigyn Technologies Limited (TTL) has received a significant boost to its employee stock option plan, as the company announced in-principle approval from both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for listing up to 4,50,000 equity shares under its Employee Stock Option Plan 2025.

Exchange Approval Details

The approval letters, issued on August 12, 2025, bear the reference numbers NSE/LIST/49438 and DCS/AMAL/RG/IP/3741/2025-26 for NSE and BSE respectively. This move allows TTL to allot equity shares to employees upon the exercise of their stock options, subject to various listing conditions.

Conditions for Approval

The exchanges have stipulated several conditions for the approval, including:

  1. Compliance with SEBI regulations
  2. Receipt of necessary statutory approvals
  3. Submission of required documentation

It's important to note that the exchanges reserve the right to withdraw approval if the submitted information is found to be incomplete or misleading.

Financial Performance

While the ESOP approval marks a positive development for Trigyn Technologies, the company's recent financial results present a mixed picture:

Consolidated Results

Particulars Q1 FY2025-26 (₹ in Lakhs) Q1 FY2024-25 (₹ in Lakhs)
Revenue from Operations 22,450.00 24,194.44
Total Income 22,894.00 24,618.50
Net Profit/(Loss) (460.86) 761.38

The company reported a consolidated revenue from operations of ₹22,450.00 lakhs, down from ₹24,194.44 lakhs in the same quarter of the previous year. More notably, Trigyn Technologies recorded a net loss of ₹460.86 lakhs, compared to a net profit of ₹761.38 lakhs in the corresponding quarter.

Standalone Results

Particulars Q1 FY2025-26 (₹ in Lakhs) Q1 FY2024-25 (₹ in Lakhs)
Revenue from Operations 3,541.02 3,667.47
Total Income 3,610.66 3,718.40
Net Profit/(Loss) (499.02) (371.45)

On a standalone basis, the company's performance also showed a decline. Revenue from operations decreased to ₹3,541.02 lakhs from ₹3,667.47 lakhs in the corresponding quarter of the previous year. The net loss widened to ₹499.02 lakhs from ₹371.45 lakhs.

Other Developments

In addition to the ESOP approval and financial results, Trigyn Technologies announced several other key developments:

  1. The Board of Directors approved the roles and responsibilities for Mrs. Bhavana Rao Potluri as Executive Vice Chair, effective immediately.

  2. The company received approval to incorporate a Wholly Owned Subsidiary in Dubai, United Arab Emirates, through its existing wholly owned subsidiary, TTI.

  3. Trigyn Technologies is currently engaged in arbitration proceedings with Nashik Municipal Smart City Development Corporation Ltd (NMSCDCL) following a termination notice issued on September 4, 2023.

  4. The company is facing a show cause cum demand notice from the GST department for ₹9.08 crores, disallowing Input Tax Credit claimed during FY 2019-20 to FY 2022-23.

As Trigyn Technologies navigates these challenges and opportunities, the approval of the ESOP 2025 could serve as a tool to attract and retain talent, which may be crucial for the company's future performance and growth strategies.

Historical Stock Returns for Trigyn Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.61%+17.55%+3.72%-19.21%-32.72%-19.43%

More News on Trigyn Technologies

1 Year Returns:-32.72%